Arkolith/Insider Trading/CABA/Form 4

Das Arun

Chief Business OfficerCabaletta Bio, Inc. (CABA) · full profile →Form 4 · filed May 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2025Grant(A)100K—$0100K
May 19, 2025Disposed to issuer(D)150K—$00
May 19, 2025Grant(A)150K—$0150K
May 19, 2025Disposed to issuer(D)100K—$00
May 19, 2025Disposed to issuer(D)35K—$00
May 19, 2025Disposed to issuer(D)18K—$00
May 19, 2025Grant(A)18K—$018K
May 19, 2025Disposed to issuer(D)100K—$00
May 19, 2025Grant(A)35K—$035K
May 19, 2025Grant(A)100K—$0100K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-074811) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML